etoposide has been researched along with Male Genitourinary Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuks, Z; Kelly, WK; Lee, H; Leibel, SA; Metz, E; Scher, HI; Schwartz, L; Smart, T; Zelefsky, MJ | 1 |
1 trial(s) available for etoposide and Male Genitourinary Diseases
| Article | Year |
|---|---|
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Estramustine; Etoposide; Gastrointestinal Diseases; Humans; Injections, Intravenous; Male; Male Urogenital Diseases; Neoadjuvant Therapy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Risk Factors; Treatment Outcome; Vinblastine; Vindesine | 2000 |